230 related articles for article (PubMed ID: 23399674)
1. [Disruption of the blood-brain barrier in inflammatory neurological diseases].
Shimizu F; Kanda T
Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674
[TBL] [Abstract][Full Text] [Related]
2. [Disruption of blood-brain barrier in multiple sclerosis and neuromyelitis optica].
Shimizu F; Kanda T
Nihon Rinsho; 2014 Nov; 72(11):1949-54. PubMed ID: 25518376
[TBL] [Abstract][Full Text] [Related]
3. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair].
Kanda T
Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier dysfunction in immuno-mediated neurological diseases.
Shimizu F; Nishihara H; Kanda T
Immunol Med; 2018 Sep; 41(3):120-128. PubMed ID: 30938273
[TBL] [Abstract][Full Text] [Related]
5. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
6. Different blood-brain-barrier disruption profiles in multiple sclerosis, neuromyelitis optica spectrum disorders, and neuropsychiatric systemic lupus erythematosus.
Jasiak-Zatońska M; Pietrzak A; Wyciszkiewicz A; Więsik-Szewczyk E; Pawlak-Buś K; Leszczyński P; Kozubski W; Michalak S; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2022; 56(3):246-255. PubMed ID: 35118639
[TBL] [Abstract][Full Text] [Related]
7. Sera from neuromyelitis optica patients disrupt the blood-brain barrier.
Shimizu F; Sano Y; Takahashi T; Haruki H; Saito K; Koga M; Kanda T
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):288-97. PubMed ID: 22100760
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
9. Neurological autoimmunity targeting aquaporin-4.
Hinson SR; McKeon A; Lennon VA
Neuroscience; 2010 Jul; 168(4):1009-18. PubMed ID: 19699271
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
Kira J
J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
[TBL] [Abstract][Full Text] [Related]
12. Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
Shimizu F; Nishihara H; Sano Y; Takeshita Y; Takahashi S; Maeda T; Takahashi T; Abe M; Koga M; Kanda T
PLoS One; 2015; 10(3):e0122000. PubMed ID: 25811465
[TBL] [Abstract][Full Text] [Related]
13. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
14. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
15. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
[TBL] [Abstract][Full Text] [Related]
16. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
17. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
Saikali P; Cayrol R; Vincent T
Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
[TBL] [Abstract][Full Text] [Related]
19. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
20. [New insights into the pathogenesis of neuromyelitis optica].
Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y
Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
